FcεRI and FcγRIII/CD16 differentially regulate atopic dermatitis in mice

Journal of Immunology

Volumn 182, Issue 10, 2009, Pages 6517-6526

  Abboud, Georges ^a   Staumont Sallé, Delphine ^a,b   Kanda, Akira ^a   Roumier, Thomas ^a   Deruytter, Nathalie ^a   Lavogiez, Céline ^a   Fleury, Sébastien ^a   Rémy, Patrick ^a   Papin, Jean Paul ^a   Capron, Monique ^a   Dombrowicz, David ^a  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; FC EPSILON RECETOR I; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 21; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; ALLERGEN; FC EPSILON RECEPTOR I BETA CHAIN, MOUSE; FC-EPSILON RECEPTOR I BETA-CHAIN, MOUSE; FCGR3 PROTEIN, MOUSE; IMMUNOGLOBULIN E RECEPTOR; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ANTIGEN PRESENTATION; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MAST CELL; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SKIN; SKIN INFLAMMATION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ANIMAL; CELL MOTION; CELL PROLIFERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALLERGENS; ANIMALS; ANTIGEN PRESENTATION; CELL MOVEMENT; CELL PROLIFERATION; DERMATITIS, ATOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOGLOBULIN E; IMMUNOHISTOCHEMISTRY; MAST CELLS; MICE; MICE, KNOCKOUT; OVALBUMIN; RECEPTORS, IGE; RECEPTORS, IGG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 70449566647     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0801055     Document Type: Article

References (52)

1. Leung, D. Y., M. Boguniewicz, M. D. Howell, I. Nomura, and Q. A. Hamid. 2004. New insights into atopic dermatitis. J. Clin. Invest. 113: 651-657.
2. Sicherer, S. H., and D. Y. Leung. 2007. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects. J. Allergy Clin. Immunol. 119: 1462-1469.
3. Larche, M., C. A. Akdis, and R. Valenta. 2006. Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 6: 761-771.
4. Kraft, S., and J. P. Kinet. 2007. New developments in FcεRI regulation, function and inhibition. Nat. Rev. Immunol. 7: 365-378. (Pubitemid 46674486)
5. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcγ receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
6. Gould, H. J., and B. J. Sutton. 2008. IgE in allergy and asthma today. Nat. Rev. Immunol. 8: 205-217.
7. Hirano, M., R. S. Davis, W. D. Fine, S. Nakamura, K. Shimizu, H. Yagi, K. Kato, R. P. Stephan, and M. D. Cooper. 2007. IgEb immune complexes activate macrophages through FcγRIV binding. Nat. Immunol. 8: 762-771. (Pubitemid 46965352)
8. Hasegawa, M., C. Nishiyama, M. Nishiyama, Y. Akizawa, K. Mitsuishi, T. Ito, H. Kawada, S. Furukawa, C. Ra, K. Okumura, and H. Ogawa. 2003. A novel -66T/C polymorphism in FcεRI α-chain promoter affecting the transcription activity: possible relationship to allergic diseases. J. Immunol. 171: 1927-1933. (Pubitemid 36966476)
9. Morar, N., S. A. Willis-Owen, M. F. Moffatt, and W. O. Cookson. 2006 The genetics of atopic dermatitis. J. Allergy Clin. Immunol. 118: 24-34.
10. Zeyrek, D., R. Tanac, S. Altinoz, A. Berdeli, F. Gulen, H. Koksoy, and E. Demir. 2008. FcγRIIIa-V/F 158 polymorphism in Turkish children with asthma bronchiale and allergic rhinitis. Pediatr. Allergy Immunol. 19: 20-24.
11. Novak, N., C. Tepel, S. Koch, K. Brix, T. Bieber, and S. Kraft. 2003. Evidence for a differential expression of the FcεRIγ chain in dendritic cells of atopic and nonatopic donors. J. Clin. Invest. 111: 1047-1056. (Pubitemid 36397481)
12. Katoh, N., S. Kraft, J. H. Wessendorf, and T. Bieber. 2000. The high-affinity IgE receptor (FcεRI) blocks apoptosis in normal human monocytes. J. Clin. Invest. 105: 183-190. (Pubitemid 30054357)
13. Kiekens, R. C., T. Thepen, I. C. Bihari, E. F. Knol, J. G. Van De Winkel, and C. A. Bruijnzeel-Koomen. 2000. Expression of Fc receptors for IgG during acute and chronic cutaneous inflammation in atopic dermatitis. Br. J. Dermatol. 142: 1106-1113.
14. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40.
15. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J. V. Ravetch. 1994. FcRγ chain deletion results in pleiotrophic effector cell defects. Cell 76: 519-529. (Pubitemid 24064172)
16. Hazenbos, W. L., J. E. Gessner, F. M. Hofhuis, H. Kuipers, D. Meyer, I. A. Heijnen, R. E. Schmidt, M. Sandor, P. J. Capel, M. Daeron, et al. 1996. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice. Immunity 5: 181-188.
17. lo thymocytes in vivo. Science 250: 1720-1723.
18. Dombrowicz, D., V. Flamand, K. K. Brigman, B. H. Koller, and J. P. Kinet. 1993. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene. Cell 75: 969-976. (Pubitemid 24014553)
19. Spergel, J. M., E. Mizoguchi, J. P. Brewer, T. R. Martin, A. K. Bhan, and R. S. Geha. 1998. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 101: 1614-1622.
20. Staumont-Salle, D., G. Abboud, C. Brenuchon, A. Kanda, T. Roumier, C. Lavogiez, S. Fleury, P. Remy, J. P. Papin, J. Bertrand-Michel, et al. 2008. Peroxisome proliferator-activated receptor α regulates skin inflammation and humoral response in atopic dermatitis. J. Allergy Clin. Immunol. 121: 962-968.e6.
21. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299.
22. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔCT) method. Methods 25: 402-408. (Pubitemid 34164012)
23. Angeli, V., D. Staumont, A. S. Charbonnier, H. Hammad, P. Gosset, M. Pichavant, B. N. Lambrecht, M. Capron, D. Dombrowicz, and F. Trottein. 2004. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J. Immunol. 172: 3822-3829. (Pubitemid 38337968)
24. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490. (Pubitemid 41587888)
25. Komai-Koma, M., D. Xu, Y. Li, A. N. McKenzie, I. B. McInnes, and F. Y. Liew. 2007. IL-33 is a chemoattractant for human Th2 cells. Eur. J. Immunol. 37: 2779-2786. (Pubitemid 47578297)
26. Spolski, R., and W. J. Leonard. 2008. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26: 57-59. (Pubitemid 351600371)
27. Samsom, J. N., L. A. van Berkel, J. M. van Helvoort, W. W. Unger, W. Jansen, T. Thepen, R. E. Mebius, S. S. Verbeek, and G. Kraal. 2005. FcγRIIB regulates nasal and oral tolerance: a role for dendritic cells. J. Immunol. 174: 5279-5287. (Pubitemid 40593166)
28. Lu, L. F., E. F. Lind, D. C. Gondek, K. A. Bennett, M. W. Gleeson, K. Pino-Lagos, Z. A. Scott, A. J. Coyle, J. L. Reed, J. Van Snick, et al. 2006. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442: 997-1002.
29. Malbec, O., and M. Daeron. 2007. The mast cell IgG receptors and their roles in tissue inflammation. Immunol. Rev. 217: 206-221. (Pubitemid 46718144)
30. Grimbaldeston, M. A., S. Nakae, J. Kalesnikoff, M. Tsai, and S. J. Galli. 2007. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat. Immunol. 8: 1095-1104.
31. Enk, A. H., and S. I. Katz. 1992. Identification and induction of keratinocyte-derived IL-10. J. Immunol. 149: 92-95.
32. Hamano, Y., H. Arase, H. Saisho, and T. Saito. 2000. Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses. J. Immunol. 164: 6113-6119. (Pubitemid 30408787)
33. Kitamura, K., K. Takeda, T. Koya, N. Miyahara, T. Kodama, A. Dakhama, T. Takai, A. Hirano, M. Tanimoto, M. Harada, and E. W. Gelfand. 2007. Critical role of the Fc receptor γ-chain on APCs in the development of allergen-induced airway hyperresponsiveness and inflammation. J. Immunol. 178: 480-488. (Pubitemid 46033632)
34. Yu, M., M. Tsai, S. Y. Tam, C. Jones, J. Zehnder, and S. J. Galli. 2006. Mast cells can promote the development of multiple features of chronic asthma in mice. J. Clin. Invest. 116: 1633-1641. (Pubitemid 43911017)
35. Dombrowicz, D., V. Flamand, I. Miyajima, J. V. Ravetch, S. J. Galli, and J. P. Kinet. 1997. Absence of FcεRI α chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis: evidence of competition between FcεRI and FcγRIII for limiting amounts of FcR β and γ chains. J. Clin. Invest. 99: 915-925. (Pubitemid 27123628)
36. Mayr, S. I., R. I. Zuberi, M. Zhang, J. de Sousa-Hitzler, K. Ngo, Y. Kuwabara, L. Yu, W. P. Fung-Leung, and F. T. Liu. 2002. IgE-dependent mast cell activation potentiates airway responses in murine asthma models. J. Immunol. 169: 2061-2068.
37. Taube, C., X. Wei, C. H. Swasey, A. Joetham, S. Zarini, T. Lively, K. Takeda, J. Loader, N. Miyahara, T. Kodama, et al. 2004. Mast cells, FcεRI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J. Immunol. 172: 6398-6406. (Pubitemid 38621249)
38. Mukai, K., K. Matsuoka, C. Taya, H. Suzuki, H. Yokozeki, K. Nishioka, K. Hirokawa, M. Etori, M. Yamashita, T. Kubota, et al. 2005. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 23: 191-202. (Pubitemid 41169288)
39. Obata, K., K. Mukai, Y. Tsujimura, K. Ishiwata, Y. Kawano, Y. Minegishi, N. Watanabe, and H. Karasuyama. 2007. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood 110: 913-920. (Pubitemid 47267429)
40. Mitchell, E. B., J. Crow, M. D. Chapman, S. S. Jouhal, F. M. Pope, and T. A. Platts-Mills. 1982. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet 1: 127-130.
41. Jawdat, D. M., E. J. Albert, G. Rowden, I. D. Haidl, and J. S. Marshall. 2004. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J. Immunol. 173: 5275-5282. (Pubitemid 39387811)
42. + Ag-mediated mast cell migration in an autocrine/paracrine fashion. Blood 105: 3222-3229.
43. Metz, M., M. A. Grimbaldeston, S. Nakae, A. M. Piliponsky, M. Tsai, and S. J. Galli. 2007. Mast cells in the promotion and limitation of chronic inflammation. Immunol. Rev. 217: 304-328. (Pubitemid 46718153)
44. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189. (Pubitemid 43214587)
45. He, R., M. K. Oyoshi, H. Jin, and R. S. Geha. 2007. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc. Natl. Acad. Sci. USA 104: 15817-15822. (Pubitemid 350035382)
46. Guttman-Yassky, E., M. A. Lowes, J. Fuentes-Duculan, L. C. Zaba, I. Cardinale, K. E. Nograles, A. Khatcherian, I. Novitskaya, J. A. Carucci, R. Bergman, and J. G. Krueger. 2008. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J. Immunol. 181: 7420-7427.
47. Bandukwala, H. S., B. S. Clay, J. Tong, P. D. Mody, J. L. Cannon, R. A. Shilling, J. S. Verbeek, J. V. Weinstock, J. Solway, and A. I. Sperling. 2007. Signaling through FcγRIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation. J. Exp. Med. 204: 1875-1889.
48. Nimmerjahn, F., and J. V. Ravetch. 2005. Divergent immunoglobulin G subclass activity through selective Fc receptor binding. Science 310: 1510-1512. (Pubitemid 41746349)
49. Tsujimura, Y., K. Obata, K. Mukai, H. Shindou, M. Yoshida, H. Nishikado, Y. Kawano, Y. Minegishi, T. Shimizu, and H. Karasuyama. 2008. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity 28: 581-589.
50. Chapman, M. D., S. Rowntree, E. B. Mitchell, M. C. Di Prisco de Fuenmajor, and T. A. Platts-Mills. 1983. Quantitative assessments of IgG and IgE antibodies to inhalant allergens in patients with atopic dermatitis. J. Allergy Clin. Immunol. 72: 27-33.
51. Avila, P. C. 2007. Does anti-IgE therapy help in asthma?: efficacy and controversies. Annu. Rev. Med. 58: 185-203.
52. Ong, Y. E., A. Menzies-Gow, J. Barkans, F. Benyahia, T. T. Ou, S. Ying, and A. B. Kay. 2005. Anti-IgE (omalizumab) inhibits late-phase reactions and in- flammatory cells after repeat skin allergen challenge. J. Allergy Clin. Immunol. 116: 558-564.